Edition:
India

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

2.36USD
9:26pm IST
Change (% chg)

$0.03 (+1.29%)
Prev Close
$2.33
Open
$2.33
Day's High
$2.39
Day's Low
$2.33
Volume
4,435
Avg. Vol
82,597
52-wk High
$4.20
52-wk Low
$1.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.00 -0.488
Mar '19 0.00 -0.597
FY 2018 Dec '18 0.00 -0.444
Sep '18 0.00 -0.492
Jun '18 0.00 -1.129
Mar '18 0.00 -0.802
FY 2017 Dec '17 0.00 -0.688
Sep '17 0.00 -0.727
Jun '17 0.00 -0.989
Mar '17 0.00 -0.798
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-19 5 3.22 16.10 0.00 0.00
Quarter Ending Mar-20 1 5.00 5.00 5.00 --
Year Ending Dec-19 5 9.22 46.10 0.00 0.00
Year Ending Dec-20 5 4.00 20.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-19 6 -0.47 0.04 -0.81 -0.44
Quarter Ending Mar-20 1 -0.31 -0.31 -0.31 --
Year Ending Dec-19 6 -1.80 -0.75 -2.53 -2.23
Year Ending Dec-20 6 -1.81 -1.16 -2.05 -1.87
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -42.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cidara Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 10.61 6.79 70 --
13 Week 0.69 -4.21 53 --
26 Week 1.39 -6.32 56 --
52 Week -35.34 -45.20 27 --
YTD -29.81 -38.36 23 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.37%
# of Holders: 56
Total Shares Held: 18,033,769
3 Mo. Net Change: -217,812
# New Positions: 1
# Closed Positions: 4
# Increased Positions: 5
# Reduced Positions: 9
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.